The Efficacy, Effectiveness, and Efficiency of Integrated QTc Assessment: Rationalizing Approaches to New Drug Modalities

Documenti analoghi

• Return to SENDer: The Submitted Electronic Data for Nonclinical Cardiovascular Studies is Not Facilitating Transparency, Translation or Innovation
  di: Matthew M. Abernathy, et al.
  Pubblicazione: (2024)
• Does Changing the Context of Use Change the Value Proposition of CiPA ?
  di: Charles T. Benson, et al.
  Pubblicazione: (2026)
• The Impact of QT‐Prolonging Medications and Drug–Drug Interactions on QTc Interval Prolongation in Hospitalized Patients: A Case‐Crossover Study
  di: Hsiu‐Ting Chien, et al.
  Pubblicazione: (2024)
• Correction to “Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing”
  Pubblicazione: (2025)
• Assessment of Efficacy Evidence for Approvals of Novel Drugs in China Between 2018 and 2022
  di: Yang Xu, et al.
  Pubblicazione: (2024)